Table 1.

Characteristics of subjects scoring above 15 on the GDS

Age/Sex	Antidepressant medications	GDS	Chart comments
39 F	venlafaxine 150 mg q day	28	Neurologist notes h/o severe depression, worsening, psychiatrist involved
	buproprion 150 mg tid
78 F	sertraline 75 mg q day	27	Neurologist aware of depression, recommends increasing sertraline dosage
87 F	None	27	No mention of depression
54 F	nortriptyline 25 mg q day	25	Neurologist repeatedly comments about depression and anxiety, noting that it is difficult to treat, psychiatrist involved
	trazodone 50 mg q day
	citalopram 20 mg q day
62 M	None	24	No mention of depression
78 M	None	23	Occasional mention of depression in chart by various providers over several years. Never diagnosed with or treated for depression
52 F	None	22	Neurologist writes to primary physician that patient has depression and panic, recommends “an SSRI”
78 M	None	22	No mention of depression
63 F	imipramine 20 mg q day (for sleep)	20	Neurologist aware of depression history.
			Pt. had been on sertaline and lorazepam in past with good response.
			Reason for d/c of these agents several months prior to rating scale not documented
46 M	paroxetine 20 mg q day	18	Depression recognized, paroxetine started one year earlier
76 F	paroxetine 20 mg q day	17	Depression recognized, paroxetine started five years earlier, dosage increased from 10mg/day to 20mg/day one year after medication started.
			Notes in chart around time of study do not mention depression
44 F	None	17	No mention of depression in chart
72 M	sertraline 100 mg/day	17	Note in chart around time of study states “depression is well-controlled on Zoloft”